[
  {
    "ts": "2025-11-30T03:13:28+00:00",
    "headline": "Why The Narrative Around Tyler Technologies Is Shifting Amid Mixed Analyst Reactions",
    "summary": "Tyler Technologies has garnered attention following recent revisions in analyst price targets. These updates are driven by new research after the company’s latest earnings report. While the stock’s fair value estimate remains steady, a slight decrease in the discount rate signals nuanced shifts in market sentiment toward the company’s risk and future prospects. Stay tuned to discover how you can remain informed as the narrative around Tyler Technologies continues to unfold. Stay updated as...",
    "url": "https://finance.yahoo.com/news/why-narrative-around-tyler-technologies-031328559.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f089b555-3675-3296-98d6-489e6d8bbbf6",
      "content": {
        "id": "f089b555-3675-3296-98d6-489e6d8bbbf6",
        "contentType": "STORY",
        "title": "Why The Narrative Around Tyler Technologies Is Shifting Amid Mixed Analyst Reactions",
        "description": "",
        "summary": "Tyler Technologies has garnered attention following recent revisions in analyst price targets. These updates are driven by new research after the company’s latest earnings report. While the stock’s fair value estimate remains steady, a slight decrease in the discount rate signals nuanced shifts in market sentiment toward the company’s risk and future prospects. Stay tuned to discover how you can remain informed as the narrative around Tyler Technologies continues to unfold. Stay updated as...",
        "pubDate": "2025-11-30T03:13:28Z",
        "displayTime": "2025-11-30T03:13:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/41bdd0c670f621394929d5266c5d6c72",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7rJTlwE09YMzxuVZu3r50Q--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/41bdd0c670f621394929d5266c5d6c72.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ymu3VW6OJp5QQmE875dokg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/41bdd0c670f621394929d5266c5d6c72.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-narrative-around-tyler-technologies-031328559.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-narrative-around-tyler-technologies-031328559.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TYL"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-30T18:58:33+00:00",
    "headline": "Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Boring Dividend Stocks to Buy. On Novemb‍er 24, Truist’​s‍ Gregor‌y Ren⁠za in​itiated coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with a Buy rating and se​t a price target of $14‌0, s‌lightly below th‌e pre​vi‌ous $1⁠45, as reported by The Fly. In‍ his note to investors,⁠ he […]",
    "url": "https://finance.yahoo.com/news/gilead-gild-earns-buy-rating-185833977.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c81a5f60-139b-3516-b057-fcfcd0306d93",
      "content": {
        "id": "c81a5f60-139b-3516-b057-fcfcd0306d93",
        "contentType": "STORY",
        "title": "Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver",
        "description": "",
        "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Boring Dividend Stocks to Buy. On Novemb‍er 24, Truist’​s‍ Gregor‌y Ren⁠za in​itiated coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with a Buy rating and se​t a price target of $14‌0, s‌lightly below th‌e pre​vi‌ous $1⁠45, as reported by The Fly. In‍ his note to investors,⁠ he […]",
        "pubDate": "2025-11-30T18:58:33Z",
        "displayTime": "2025-11-30T18:58:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5",
          "originalWidth": 1920,
          "originalHeight": 1297,
          "caption": "Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PSxIzcY_BXa.RVyX155p6g--~B/aD0xMjk3O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5.cf.webp",
              "width": 1920,
              "height": 1297,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BN3qCh8k0fiWexwcg2uacA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-gild-earns-buy-rating-185833977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-gild-earns-buy-rating-185833977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]